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Density functional theory calculation results dem-
onstrated that the efficiency of the acid-catalyzed
hydrolysis of Kirby’s acid amides 1–15 is strongly
dependent on the substitution on the C–C double
bond and the nature of the amide N-alkyl group.
Further, the results established that while in the
gas phase the hydrolysis rate-limiting step is the
tetrahedral intermediate formation in polar sol-
vents such as water, the rate-limiting step could
be either the formation or the collapse of the tet-
rahedral intermediate depending on the substitu-
tion on the C–C double bond and on the amide
nitrogen substituent. Based on a linear correlation
between the calculated and experimental effective
molarities, the study on the systems reported
herein could provide a good basis for designing
prodrug systems that are less hydrophilic than
their parental drugs and can be used, in different
dosage forms, to release the parent drug in a
controlled manner. For example, based on the
calculated log effective molarities values, the pre-
dicted t1/2 (a time needed for 50% of the reactant
to be hydrolyzed to products) for acyclovir
prodrugs, ProD 1–4, was 29.2 h, 6097 days,
4.6 min, and 8.34 h, respectively. Hence, the rate
by which acyclovir prodrug releases acyclovir can
be determined according to the structural features
of the linker (Kirby’s acid amide moiety).
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Acyclovir is a synthetic acyclic purine nucleoside analog that is the
first agent to be licensed for the prevention and treatment for viral
infections such as herpes simplex (HSV), varicella zoster (chicken
pox), and herpes zoster (shingles) (1). Acyclovir is poorly water soluble
and has an oral bioavailability of 10–20%; hence, intravenous admin-
istration is necessary if high dosing is required. When orally adminis-
tered, peak plasma concentration occurs after 1–2 h. Acyclovir has a
high distribution rate with only 30% is protein-bound in plasma. The
elimination half-life of acyclovir is about 3 h. It is renally excreted by
both glomerular filtration and tubular secretion (2).
Acyclovir is marketed as tablets of 200, 400, and 800 mg, suspen-
sion for oral administration, intravenous injection, and ophthalmic
and skin topical creams. Per os acyclovir is mostly used as 200 mg
tablets, five times daily. In addition, 6 month to a year administra-
tion of acyclovir is required in immunocompetent patient with
relapsing herpes simplex infection (2).
The currently available oral administration therapy is associated
with a number of drawbacks such as highly variable absorption and
low bioavailability (10–20%). The main problem with the therapeu-
tic effectiveness of acyclovir is its absorption that is highly variable
and dose dependent, thus reducing the bioavailability to 10–20%.
In commercially available dosages forms of acyclovir, the amount of
drug absorbed is very low because of short residence time of the
dosage forms at the absorption site. In humans, acyclovir showed
poor and variable oral bioavailability (10–20%), probably due to the
relatively low lipophilicity of the drug. Thus, the rate-limiting factor
in acyclovir absorption is its membrane permeability (3).
Several approaches have been made to improve the oral bioavail-
ability of acyclovir: (i) Luengo et al. have used different preparations
of acyclovir with b-cyclodextrin in order to increase its solubility
and hence its bioavailability; however, no significant effect of b-
cyclodextrin on the oral drug bioavailability was observed. This was
attributed to the effect of b-cyclodextrin only on the solubility and
not on the permeability of the drug (4). (ii) Encapsulation of
acyclovir in lipophilic vesicular structure was carried out to enhance
the oral absorption and prolong the existence of the drug in the
systemic circulation. This was accomplished by niosomes (non-ionic
surfactant vesicles) that are well recognized as drug delivery
vehicles. In vivo study by El-Gizawy and coworkers using niosomal
formulation revealed that the niosomal dispersion significantly
improved the oral bioavailability of acyclovir in rabbits after a single
oral dose of 40 mg ⁄ kg. The average relative bioavailability of the
drug from the niosomal dispersion in relation to the free solution
indicated more than twofold increase in drug bioavailability. The
niosomal dispersion showed significant increase in the mean
residence time of acyclovir reflecting sustained release characteris-
tics (5). (iii) Yadav et al. have used acyclovir-loaded mucoadhesive
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microspheres for increasing the retention time and hence the
bioavailability of acyclovir. Their study revealed that the micro-
spheres prepared from sodium CMC having high mucoadhesiveness
and fair entrapment efficiency enabled the sustained release of
acyclovir from microspheres and plasma drug concentration in rab-
bits was maintained for 24 h (6), and (iv) the search for an effective
prodrug that would provide acyclovir with higher bioavailability led
to the synthesis of a number of aliphatic and amino acid esters of
acyclovir. Among these compounds was the L-valyl ester, valacyclo-
vir HCl (Scheme 1). Valacyclovir has greater oral bioavailability
(about 55%) than acyclovir (10–20%). It is converted by esterases
to the active drug acyclovir, as well as the amino acid valine, via
hepatic first-pass metabolism (7). Another prodrugs approach for
enhancing acyclovir oral bioavailability was by utilizing the human
apical sodium-dependent bile acid transporter (hASBT). Using each
chenodeoxycholate, deoxycholate, cholate, and ursodeoxycholate,
four bile acid prodrugs of acyclovir were synthesized, where acyclo-
vir was conjugated to a bile acid via a valine linker. Relative to cel-
lular uptake studies of acyclovir alone, the cellular uptake from the
prodrug resulted in a 16-fold greater acyclovir accumulation within
hASBT-COS cells, indicating enhanced permeation properties of the
prodrug. Enhanced permeability was attributable to hASBT-mediated
uptake and increased passive permeability. Furthermore, it was
found that oral administration of acyclovir valylchenodeoxycholate
to rats resulted in a twofold increase in the bioavailability of acy-
clovir, compared with the bioavailability after the administration of
acyclovir alone (8).
After reviewing the literature on the physical properties and phar-
macokinetics of acyclovir, it is quite safe to assume that its low
bioavailability is attributable mainly to inefficient permeability
through membranes rather than its insolubility in physiologic envi-
ronments, especially in acidic medium such as stomach. Hence,
improvement of acyclovir pharmacokinetic properties and hence
their effectiveness may increase the absorption of acyclovir via a
variety of administration routes. This can be achieved by utilizing a
carrier-linked prodrug strategy which could be done by linking acy-
clovir to a carrier moiety to furnish a drug-host system which upon
exposure to physiological environment, such as stomach or intes-
tine, can penetrate the membrane tissues and liberate the active
drug, acyclovir, in a controlled manner.
The approach of covalently linking a valyl moiety to acyclovir free
hydroxyl group to give the ester derivative of acyclovir (valacyclovir)
had succeeded to increase the antiviral drug bioavailability approxi-
mately threefold (from 20% to 55%) (7). However, further improve-
ment of the structural features of acyclovir is still to be made in
order to obtain a prodrug that might have a higher bioavailability
than the current prodrug (valacyclovir). It should be noted that valacy-
clovir prodrug might suffer from partial hydrolysis by esterases upon
reaching the stomach that results in a decrease in its bioavailability.
For achieving acyclovir prodrug with higher bioavailability, the pro-
drug must be characterized with the following properties: (i) to be
readily soluble in a physiological medium, (ii) to have a moderate
hydrophilic–lipophilic balance (HLB) value such that allowing an effi-
cient permeability, (iii) to release the active drug in a controlled
manner once it reaches the target, and (iv) to yield upon cleavage
a safe and non-toxic by-products. By making a prodrug with these
physical and chemical properties, the following goals might be
accomplished: (i) a relatively high permeability of the prodrug
through the tissues, (ii) a higher feasibility for using the drug in dif-
ferent dosage forms, (iii) a chemically driven system that liberates
acyclovir in a controlled manner upon reaching the human blood cir-
culation system, and (iv) an antiviral drug with physical–chemical
properties such that leading to a high bioavailability and efficient
pharmacokinetic properties.
A large number of prodrugs have been designed and developed in
order to improve the effectiveness of certain drugs and to overcome
pharmaceutical and pharmacokinetic barriers upon drug administra-
tion, such as low absorption, chemical instability, low solubility, and
poor patient compliance. For example, valacyclovir prodrug was
designed and synthesized in order to overcome low permeability of
acyclovir. Valacyclovir design was based on biochemical approach
by which the prodrug will be hydrolyzed to acyclovir by esterase
enzymes once it penetrates the membrane tissues (7).
Recently, we have been investigating the mechanisms for some
intramolecular processes that have been utilized to understand
enzyme catalysis and lately have been exploited as prodrug linkers
(9–17). Using density functional theory (DFT) and ab initio molecular
orbital methods, we have studied various intramolecular processes
among them: (i) proton transfer between two oxygens in Kirby's ace-
tals (11), and proton transfer between nitrogen and oxygen in Kirby's
enzyme models (15,18–27), (ii) proton transfer between two oxygens
in rigid systems as investigated by Menger (9,28–35), and (iii) proton
transfer from oxygen to carbon in some of Kirby's enol ethers
(16,18–27) arriving at the following conclusions: (i) rate enhancement
in intramolecular processes is a result of both entropy and enthalpy
effects. In intramolecular cyclization processes where enthalpic
effects were predominant, steric effects was the driving force for
the accelerations, whereas proximity orientation was the determin-
ing factor in the cases of proton-transfer reactions. (ii) The distance
between the two reacting centers is the main factor to determine
whether the reaction type is intermolecular or intramolecular. In the
cases by which the distance exceeded 3 , an intermolecular
Scheme 1: Chemical structures for acyclovir, valacyclovir, and
drug-host.
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engagement was preferred because of the involvement of a water
molecule (solvent), whereas an intramolecular engagement prevailed
when the distance between the electrophile and nucleophile was
<3 . (iii) The efficiency of proton transfer between two oxygens
and between nitrogen and oxygen in Kirby's enzyme models is attrib-
uted to a relatively strong hydrogen bonding developed in the prod-
ucts and the transition states leading to them.
We have learned from our recent studies on intramolecularity that
there is a crucial necessity to investigate the reaction mechanism
for assigning the factors determining the reaction rate for a better
design of an efficient chemical device to be exploited as prodrug
linker and to have the potential to chemically (not via enzymes) lib-
erate the active drug in a programmable (controlled) manner. For
example, we have explored the mechanism for the proton transfer
in Kirby's acetals (18–27), and based on our findings, we have
designed prodrugs of aza nucleosides for the treatment of myelo-
dysplastic syndromes where the prodrug linker is attached to the
hydroxyl group of the nucleoside (15). In addition, prodrugs of par-
acetamol capable of masking the bitter taste of the parental drug,
paracetamol, were also designed such that the linker is covalently
linked to the phenolic group of paracetamol which is believed to be
responsible for the bitterness of the drug (17). The prodrugs were
designed such that they will undergo cleavage reactions in physio-
logical environments such as stomach at pH 1.5, intestine at pH
6.5, and ⁄ or blood circulation at pH 7.4, with rates that are solely
dependent on the structural features of the pharmacologically inac-
tive linker. Different linkers were also investigated for the design of
large number of prodrugs, such as anti-Parkinson, antimalarial, and
antihypertensive, that might be efficient in releasing the parental
drugs in various rates that are dependent on the nature or the
structural features of the linkers (13).
To expand our approach for utilizing intramolecularity to design
potential linkers for amine drugs, we have studied the mechanism
and driving forces determining the rate of the acid-catalyzed hydro-
lysis in some of Kirby's acid amides (prodrugs linkers) (36,37). This
work was carried out with the hope that such linkers might have a
potential to be good carriers to the antiviral agent, acyclovir.
Based on the DFT calculation results on the acid-catalyzed hydroly-
sis of amide acids 1–15 reported herein (Scheme 2), four acyclovir
prodrugs are proposed (Scheme 3). As shown in Scheme 3, the acy-
clovir prodrugs, ProD 1–ProD 4 are composed of the amide acid
linker having a carboxylic acid group (hydrophilic moiety) and the
rest of the prodrug molecule (a lipophilic moiety). The combination
of both groups secures a prodrug moiety having a potential to be
with a high permeability (a moderate HLB). It should be emphasized
that the HLB value of the prodrug moiety will be dependent on the
pH of the target physiologic environment. In the stomach, it is
expected that prodrugs ProD 1–4 will be in the carboxylic acid
form (a relatively high lipophilicity), whereas in the blood circulation
system the carboxylate anion form (a relatively low lipophilicity) will
be predominant. The plan is to prepare ProD 1–4 (Scheme 3) as
sodium or potassium carboxylate salts owing to their stability in
neutral aqueous medium. It should be noted that acid amides such
as 1–15 undergo hydrolysis in acidic aqueous medium, whereas
they are relatively stable at pH 7.4.
In this article, we report a DFT computational study on intramolecu-
lar acid-catalyzed hydrolysis of 15 maleamic (4-amino-4-oxo-2bute-
noic) acids, 1–15 (Scheme 2). Based on the calculated and
experimental rates for processes 1–15, the t1 ⁄ 2 values (the time
needed for 50% of the prodrug to be hydrolyzed to the antiviral
drug, acyclovir) for ProD 1–4 were evaluated.
The aims of this work were to (i) study the mechanistic behavior of
the acid-catalyzed hydrolysis for several maleamic acid amides hav-
ing different alkyl groups on the amide nitrogen and different sub-
stitution on the carbon–carbon double bond and unravel the nature
Scheme 2: Chemical structures for 1–15.
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of the force(s) affecting the rate as a function of these substitu-
tions, and (ii) design of various acyclovir prodrugs that are relatively
tissue permeable and have the capability to undergo chemical
hydrolysis (not enzymatic) in physiological environment to provide
acyclovir in a sustained release manner.
Calculations Methods
The Becke three-parameter, hybrid functional combined with the
Lee, Yang, and Parr correlation functional, denoted B3LYP, was
employed in the calculations using DFT. All calculations were made
using the quantum chemical package Gaussian-98a. Calculations
were made based on the restricted Hartree–Fock methoda. The
starting geometries of all calculated molecules 1–15, Inter, and
ProD 1–4 were obtained using the Argus Lab program (38) and
were initially optimized at the HF ⁄ 6-31G level of theory in the pres-
ence of one molecule of water, followed by optimization at the
B3LYP ⁄ 6-31G(d,p). Systems 1–3 were also calculated at
B3LYP ⁄ 311 + G (d,p) level and at the density functional from Truhlar
group (hybrid GGA: MPW1k) (39). Total geometry optimizations
included all internal rotations. Second derivatives were estimated
for all 3N-6 geometrical parameters during optimization. The search
for the global minimum structure (GM) in each of the systems stud-
ied was accomplished by 360 rotation of the carboxylic group
about the bond C6–C7 (i.e., variation in the dihedral angle
O1 ⁄ C7 ⁄ C6 ⁄ C5, Chart 1) and by 360 rotation of the carbonyl amide
group about the C4–C5 bond (i.e., variation in the dihedral angle
O3 ⁄ C4 ⁄ C5 ⁄ C6) in increments of 10 and calculation of the confor-
mational energies (see Chart 1). In the DFT calculations for 1–15
and ProD 1–4, two types of conformations in particular were con-
sidered: one in which the amide carbonyl is syn to the carboxyl
group and another in which it is anti. An energy minimum (a stable
compound or a reactive intermediate) has no negative vibrational
force constant. A transition state is a saddle point that has only
one negative vibrational force constant (40). Transition states were
located first by the normal reaction co-ordinate method (41) where
the enthalpy changes were monitored by stepwise changing the in-
teratomic distance between two specific atoms. The geometry at
the highest point on the energy profile was re-optimized by using
the energy gradient method at the B3LYP ⁄ 6-31G(d,p) level of the-
orya. The 'reaction co-ordinate method' (41) was used to calculate
the activation energy in maleamic (4-amino-4-oxo-2butenoic) acids,
1–15, and ProD 1–4 (Schemes 2 and 3). In this method, one
bond length is constrained for the appropriate degree of freedom,
while all other variables are freely optimized. The activation energy
values for the approach processes (the approach of O1 toward C4,
Chart 1) were calculated from the difference in energies of the GM
and the derived transition states (TS2 in Scheme 4). Similarly, the
activation energies of the dissociation processes (the breakdown of
C4–N9 bond, Chart 1) were calculated from the difference in ener-
gies of the GM and the corresponding transition states (TS3 in
Scheme 4). Verification of the desired reactants and products was
accomplished using the 'intrinsic co-ordinate method' (41). The tran-
sition-state structures were verified by their only one negative fre-
quency. Full optimization of the transition states was accomplished
after removing any constrains imposed while executing the energy
Scheme 3: Chemical structures for ProD 1–4.
Chart 1: Chemical representation of the syn and anti conforma-
tions for the global minimum structures (GM).
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profile. The activation energies obtained from the DFT at B3LYP ⁄ 6-
31G (d,p) level of theory for 1–15, ProD 1–4, and Inter were
calculated with and without the inclusion of solvent (water and
ether). The calculations with the incorporation of a solvent were
made using the integral equation formalism model of the polariz-
able continuum model (42–45). In this model, the cavity is created
via a series of overlapping spheres. The radii type employed was
the United Atom Topological Model on radii optimized for the
PBE0 ⁄ 6-31G (d) level of theory.
Results and Discussion
In 1968, Dixon and Perham observed that the half amide formed by
the reaction of arginine with dimethylmaleic anhydride is hydrolyzed
more rapidly than that of the unsubstituted maleic acid derivatives
(46). This observation had led Kirby and coworkers to investigate
those structural factors associated with high reactivity in the intra-
molecular acid-catalyzed hydrolysis of nine maleamic (4-amino-4-
oxo-2butenoic) acids (36,37). They found that the efficiency of the
intramolecular hydrolysis is remarkably sensitive to the pattern of
substitution on the carbon–carbon double bond. Further, their study
revealed that the rates of the hydrolysis of the nine amide acid
derivatives studied range over more than 1010. Furthermore, they
have concluded that the amide bond cleavage is because of intra-
molecular nucleophilic catalysis by the adjacent carboxylic acid
group, and the rate-limiting step is the one by which dissociation
of the tetrahedral intermediate occurs (36). Later on, Kluger (47)
had studied the intramolecular hydrolysis mechanism of eight
maleamic acids derived from aliphatic amines of a wide range of
basicity. His study revealed that the identity of the rate-limiting
step is a function of both the basicity of the leaving group and the
acidity of the solution. In 1990, Katagi has computationally studied
the acid-catalyzed hydrolysis of three maleamic (4-amino-4-oxo-
2butenoic) acids using the semiempirical method AM1. In contrast
to that found by Kirby, Katagi's study revealed that the rate-limiting
step is the formation of the tetrahedral intermediate and not its
collapse (48).
As Katagi's semiempirical calculations were run in the presence of
only two molecules of water which resembles somewhat the gas-
phase environment, we sought to study the acid-catalyzed hydroly-
sis reactions of a variety of maleamic acid amide derivatives using
Becke three-parameter hybrid functional combined with the Lee,
Yang, and Parr correlation functional (B3LYP) methods, which are
superior to semiempirical methods, and to run the calculations in
the gas phase as well as in other solvents such as ether and water
because of the importance of the solvent in stabilizing or destabiliz-
ing the chemical entities involved in the hydrolysis.
As shown in Scheme 2, the 15 maleamic acid amide derivatives dif-
fer in the substituents attached to the carbon–carbon double bond
and ⁄ or the alkyl group attached to the amide nitrogen. Replacing
the N-alkyl amide group in 1–15 (Scheme 2) with acyclovir drug, as
shown for ProD 1–ProD 4 in Scheme 3, is not expected to affect
significantly the relative rates of these processes. Hence, computa-
tions of the kinetic and thermodynamic parameters for processes 1–
15 will shed light on the rates for the acid-catalyzed hydrolysis of
prodrugs ProD 1–ProD 4 to the antiviral drug, acyclovir.
For the use of systems 1–15 as prodrug linkers of acyclovir as
shown in Scheme 3, the reaction mechanism for the hydrolysis of
Scheme 4: Proposed mechanism for processes 1–15. PT refers to proton transfer. TETF and TETD refer to tetrahedral intermediate forma-
tion and dissociation, respectively. GM, TS, INT, and P are global minimum, transition-state, intermediate and product structures, respectively.
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1–15 should be unraveled. As mentioned above, only one mecha-
nism was suggested for this reaction; however, the question which
step is the rate-limiting one is still in debate. Two different rate-
limiting steps were proposed: (i) a step that involves the formation
of a tetrahedral intermediate (48) and (ii) a step by which the tetra-
hedral intermediate dissociates to provide products (Scheme 4) (36).
In order to determine the rate-limiting step, DFT calculations at the
B3LYP ⁄ 6-31G (d,p) level were made in the gas phase as well as in
ether and water.
Computational efforts were directed toward the elucidation of the
transition-state and ground-state structures (reactants, intermedi-
ates, and products) for the acid-catalyzed hydrolysis of 1–15 (49)
and ProD 1–4. Calculations for all entities were made in the pres-
ence of one and two molecules of water in the gas phase as well
as in water and ether as solvents. It is expected that the stability
of the ground states and transition states will be different in sol-
vent having low dielectric constant, such as the gas phase or ether,
and solvent with high dielectric constant, such as water.
General consideration
Because the energy of a carboxylic acid amide moiety is strongly
dependent on its conformation which could be engaged in inter- or
intramolecular hydrogen bonding, we were concerned with the iden-
tification of the most stable conformation (global minimum) for each
of the maleamic acid amides 1–15 and ProD 1–4. This was
accomplished by 36 rotations of the carboxyl group about the bond
C6–C7 in increments of 10 (i.e., variation in the dihedral angle
O1 ⁄ C7 ⁄ C6 ⁄ C5, see Chart 1) and by 360 rotation of the carbonyl
amide group about the bond C4–C5 (i.e., variation in the dihedral
angle O3 ⁄ C4 ⁄ C5 ⁄ C6) in increments of 10 and calculation of the
conformational energies (see Chart 1).
In the DFT calculations of the starting geometries in 1–15 and ProD
1–4, two different types of conformations were considered: one in
which the amide carbonyl is syn to the carboxyl group and another in
which it is anti (Chart 1). It was found that the GM for 1–15 and
ProD 1–4 all reside in the syn conformation (see Figure 1A).
Optimized structures for the entities involved
in the acid-catalyzed hydrolysis of maleamic
acid amides 1–15 and ProD 1–4
Reactants (GM)
Because the acid-catalyzed hydrolysis of the maleamic acid amide
derivatives was conducted in aqueous medium, we have calculated
the geometries of all entities involved in these hydrolysis reactions
in the presence of one and two water molecules and in the gas
phase (without any molecule of water). This was carried out in
order to account for any specific intermolecular hydrogen bonding
between water and the reactant. DFT-optimized geometries along
with selected bond distances and bond angles for the reactants of
1–15 and ProD 1–4, 1GM–15GM, and ProD 1GM–4GM,
respectively, are illustrated in Figures 1A and 2A and listed in
Table 1. Careful examination of the calculated geometries in
Figures 1A and 2A indicates that all the reactants exhibit conforma-
tions by which the carboxyl group is engaged intramolecularly in a
hydrogen bond with the neighboring amide oxygen to form a seven-
membered ring. In the geometries of 1–15, the seven-membered
ring is quite normal; however, the ring in the geometries of ProD
1–4 is somewhat distorted because of the engagement of the car-
boxyl hydroxyl group in a hydrogen bond with the amine hydrogen
of the neighboring amide group (see Figure 2A). The calculated
B3LYP ⁄ 6-31G (d,p) intramolecular hydrogen bonding length (rGM in
Chart 1) in 1GM–15GM was found in the range of 1.50–1.82 ,
and that for the hydrogen bond angle e (O1H2O3 in Chart 1) in the
range of 143.6–172.4. On the other hand, the DFT calculated rGM
and e for ProD 1–4 were 3.72–4.04  and 39.3–53.1, respec-
tively. In addition, the calculated values for angles a and b in
1GM–15GM and ProD 1GM–4GM were in the range of
119.6–130.9 and 120.6–133.7, respectively. Inspection of Table 1
indicates that the calculated values for the interatomic distance
between the carboxyl hydroxyl oxygen and the amide carbonyl car-
bon (rAP, Chart 1) range between 2.69 and 3.20 , whereas the
value range of the angle of attack h (Chart 1) was 49.7–104.1.
Transition-state geometries for the tetrahedral
intermediate formation (TS2)
The calculated DFT-optimized structures for the transition states of
the tetrahedral intermediate formation in 1–15 and ProD 1–4
(1TS2–15TS2, ProD 1TS2–ProD 4TS2) are summarized in
Table 2 and those of 10TS2–15TS2, ProD 1TS2–ProD 4TS2
are illustrated in Figures 1B and 2B, respectively. Examination of
the properties of the optimized geometries of the transition states
(TS2) demonstrated that all of them resemble that of the corre-
sponding GM. The calculated O–C distance in all the transition
states was 2.30 . The angles a and b were quite similar to that
of the corresponding GM structures. The values of the a angle in
1TS2–15TS2 were found in the range 113.8–123.1, and those of
the b were in the range 115.7–118.9. On the other hand, the cal-
culated a and b values for ProD 1TS2–ProD 4TS2 were in the
range 113.4–119.8 and 117.2–119.0, respectively.
Tetrahedral intermediate geometries (INT2)
The calculated parameters for the tetrahedral intermediate struc-
tures of 1–15 (1INT2–15INT2) and ProD 1INT2–4INT2 are
shown in Figures 1C and 2C and are listed in Table 1. Careful
inspection of the values in Table 1 revealed that angles a and b
values in the intermediates are reduced when compared to that of
the corresponding reactants. The a values were found in the range
107.2–110.7, whereas for the b values the range was 107.2–
111.4. Furthermore, the angles around the tetrahedral carbon were
in the range for similar regular tetrahedral intermediates.
Transition-state geometries for the tetrahedral
intermediate dissociation (TS3)
The calculated DFT geometries for the transition state of the tetra-
hedral intermediate dissociation step in 1–15 and ProD 1–4
(1TS3–15TS3 and ProD 1TS3–ProD 4TS3, respectively)
resemble that of the corresponding tetrahedral intermediates. The
angle a and b values are quite identical in both the tetrahedral
intermediates and their corresponding transition states. The a val-
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ues were found in the range 107.0–108.4, and values of the b
were in the range 108.3–109.2.
Mechanistic investigation
The DFT at B3LYP ⁄ 6-31G (d,p) level of theory kinetic and
thermodynamic properties for all possible routes for the acid-cata-
lyzed hydrolysis reactions of acid amides 1–15 and ProD 1–4
(Scheme 4) were calculated using the quantum chemical package
Gaussian-98a.
The enthalpy and entropy energy values for all entities involved in the
hydrolysis (GM, products (P), transition states, TS1, TS2, and TS3, and
intermediates, INT1, INT2, and INT3) were calculated in the gas phase
A
B
Figure 1: (A) Density functional theory (DFT)-optimized structures for 1GM–15GM. (B) DFT-optimized structures for 10TS2–15TS2. (C)
DFT-optimized strucures for 1INT2–15INT2. GM, global minimum structures. For Cartesian co-ordinates for optimized structures see Appen-
dix S1.
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and water. Table 2 lists the energy values for 1GM–15GM, ProD
1GM–ProD 4GM, 1INT2–15INT2, ProD 1INT2, ProD
4INT2, 10TS2–15TS2, 1TS3–9TS3, ProD 1TS2, and ProD
4TS2. Figures 1A–C and 2A–C show the DFT-optimized structures for
some of the GM, INT2, TS2, and TS3 in 1–15 and ProD 1–4.
Using the calculated DFT values for the enthalpy and entropy of the
GM and the transition states in the hydrolysis of 1–15 and ProD
1–4, the barriers (DG) for all steps described in Scheme 4 were
calculated in the gas phase, in dielectric constant of 4.5 (ether) as
well as in a dielectric constant of 78.39 (water). The activation
energy values for those barriers are summarized in Tables 3 and 4.
Inspection of the DGzF , activation energy for the tetrahedral inter-
mediate formation and DGzB, for that of the tetrahedral intermedi-
ate breakdown) values listed in Tables 3 and 4 demonstrated that
the rate-limiting step in the acid-catalyzed hydrolysis of 1–15 and
ProD 1–4 is dependent on three factors: (i) the alkyl substituents
on the C–C double bond, (ii) the medium by which the calculations
were made, and (iii) the N-alkyl substituent.
The factors affecting the hydrolysis rate
The substituents on the C–C double bond
In order to assign the factors affecting the reaction rate in systems
1–15 and ProD 1–4, it will be a must to assign first the rate-lim-
iting step for the whole process. A careful inspection of Table 3
indicates that the gas-phase calculated free activation energies for
the formation step (DGzFGP) are much higher than that of the corre-
sponding energies for the dissociation step (DGzBGP). This demon-
strates that the rate-limiting step in apolar solvents is the one by
which a tetrahedral intermediate is formed (Scheme 4). When com-
paring the reactivities of the acid amides having the same N-alkyl
group (systems 1–9), an interesting observation is emerged which
indicates the existence of two significant trends in the reactivity
versus the structural features of the ground-state structure. These
two structural parameters are the distance between the carboxyl
oxygen and the amide oxygen in the reactant, rAP (Chart 1), and the
attack angle h (Chart 1). As shown in Table 3, systems having reac-
tants with short rAP and large h values are more reactive than
those with long rAP and small h values. For example, the distance
for the unsubstituted maleamic acid amide 1 is 3.16  with activa-
tion energy (DGzFGP) of 33.53 kcal ⁄mol, whereas for the dimethyl-
substituted derivative 2, the distance and DGzFGP are 3.05  and
27.08 kcal ⁄mol, respectively. In fact, when the values of rAP and h
were examined for correlation with the gas phase and water calcu-
lated free activation energies (DGzB), good correlations with correla-
tion coefficient of R = 0.84–0.90 were obtained (Figure 3A,B).
In order to shed light on the factor determining the values of the
distance between the two reactive centers (rAP) and the angle of
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accelerations in rate for some of the derivatives such as system 2,
we have calculated, using Allinger's MM2 method (50), the strain
energy values for the reactants (GM), intermediates (INT2), and
products (P) in 1–15 and ProD 1–4. The MM2 strain energies
(Es) for these structures are listed in Table 4. The MM2 calculated
Es (INT-GM) values were examined for correlation with the experi-
mental and water calculated activation energies (Table 4). Strong
correlation with a correlation coefficient R = 0.94–0.97 was
obtained. In addition, good correlation was found between the acti-
vation energies and the strain energies of the intermediates (Es
(INT2)). The results shown in Figure 3C indicate that the rate of the
reaction for systems having small difference in the strain energies
of their intermediates and corresponding reactants such as 2 and 5
is higher than that having larger values such as 1 and 4. This
might be attributed to the fact that the transition-state structures
in 1–9 resemble those of the corresponding intermediates (Fig-
ure 3C).
Furthermore, the effect of the C–C double bond substituents on the
reactivity of the acid amide was also investigated. Examination of
Tables 3 and 4 indicates that the substituents have an effect on
both the tetrahedral intermediate formation and its collapse. In
order to test whether the substituent on the double bond has the
same effect on the tetrahedral intermediate formation and the tet-
rahedral intermediate collapse, the DFT calculated activation ener-
gies in the gas phase and in water for the formation of the
tetrahedral intermediate (DGzF ) were correlated with the energy val-
ues needed for its collapse (DGzB). The correlation results illustrated
in Figure 3D indicate strong correlations with a correlation coeffi-
cient R = 0.92 and 0.95, respectively. The linear correlation indi-
cates that the driving force for the formation and collapse of the
tetrahedral intermediate is the same and the rate of the acid-cata-
lyzed hydrolysis is dependent on strain effects.
The combined results might be able to test some theories such as
Koshland's 'orbital steering' and Bruice's and Menger's 'proximity
orientation' that were invoked to account for rate accelerations in
intramolecular and enzymatic processes.
The solvent (medium) effect
Careful examination of the energy data listed in Tables 3 and 4
reveals that while the rate-limiting step (higher barrier) in the gas
phase for all systems studied (1–15 and ProD 1–4) is the forma-
tion of the tetrahedral intermediate (the free activation energy for
the tetrahedral intermediate formation is about 0.5–15 kcal ⁄mol
higher than that for its breakdown), the picture in water and ether
is somewhat different.
For systems 1–9, the rate-limiting step in water is the collapse of
the tetrahedral intermediate (energy difference between the col-
lapse and formation barriers is 2–7 kcal ⁄mol), whereas in processes
10–15 and ProD 1–4, the formation of the tetrahedral intermedi-
ate is the step that determines the rate of the hydrolysis reaction
(energy difference between the formation and collapse barriers is
5–30 kcal ⁄mol). Inspection of Tables 3 and 4 and Scheme 4
revealed that the step most powerfully affected by structural




Figure 2: (A) Density functional theory (DFT)-optimized structures
for ProD 1GM–ProD 4GM. (B) DFT-optimized structures for
ProD1 TS2–ProD4 TS2. (C) DFT-optimized structures for
ProD1 INT2–ProD4 INT2. GM, global minimum structures.
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tetrahedral intermediate INT2. Examination of the geometries of the
transition states for this step (TS2) indicates that TS2 is in the ionic
form. It is expected that the effect of polar solvents on the stability
of TS2 will be different from that of solvents with less polarity. The
free activation energies for the approach process (DGzF ) and the
dissociation process (DGzB) calculated in the gas phase, ether and
in presence of water listed in Tables 3 and 4 indicate that solvents
with low dielectric constant such as in the case of the gas phase
tend to shift the equilibrium to the reactants by destabilizing TS2,
making the approach step as the rate limiting, whereas solvents
with high dielectric constants such as water interact strongly with
the ionic transition state to affect the equilibrium to be shifted to
the right side. These interactions stabilize the approach transition
state (TS2) and consequently lower the approach barrier, hence
making the reaction rate dependent on the dissociation step. A rep-
resentation of the energy profiles for the hydrolysis of ProD 1 and
2 as calculated in water is illustrated in Figure 4.
On the other hand, when comparing the effect of ether as a solvent
on the reaction rates of 1–9, the DFT calculation results indicate
that in the presence of ether (dielectric constant = 4.5), the rate-
limiting step in systems 2 and 5 is the formation of the tetrahedral
intermediate, whereas in the other processes the rate-limiting step
is the dissociation of the tetrahedral intermediate (see Tables 3 and
4).
The N-alkyl substituent
In order to study the role of the leaving group on the mode and
the nature of the intramolecular acid-catalyzed hydrolysis mecha-
nism of acid amides systems having different leaving groups
(groups with different pKa and bulkiness), systems 10–15 were
computationally investigated and their calculated properties were
compared to those for 1–9. Compounds 10–15 represent different
systems by which the leaving group NHMe is replaced with more
or less basic leaving groups. Compounds 10–12 are examples of
systems having less basic leaving groups (NHCF3 and N(CF3)2),
whereas compounds 13–15 represent those with more basic leav-
ing group (N(Me)2). The DFT calculation results revealed that the
rate-limiting step in 10–15 is the formation of the tetrahedral
intermediate and not its collapse as observed with systems 1–9. In
addition, the energy difference between the two barriers (the for-
mation and collapse) was largely affected by the nature of the leav-
ing group. For example, the higher barrier in system 1 was the
collapse step and the energy difference between the collapse and
the formation barriers was about 7 kcal ⁄mol, whereas in systems
10 and 11 which are similar to 1 except that the leaving group in
10 is NHCF3 and in 11 is N(CF3)2, the rate-limiting step was the
formation of the tetrahedral intermediate and the energy difference
between the two barriers was )4.4 kcal ⁄mol for 10 and
)17.4 kcal ⁄mol for 11. Furthermore, when the leaving group in 1
was replaced with N(Me)2 such as in 13, the energy difference
between the two barriers was about )5.5 kcal ⁄mol. Furthermore,
strong correlation was obtained when the strain energy difference
between the intermediates and the corresponding reactants (Es INT-
GM) was plotted against the water free activation energy of sys-
tems 10–15 and ProD 1–4 with a correlation coefficient of
R = 0.90. This indicates that in addition to other effects, strain
effect has a profound effect on the rates of the reactions in 10–
15 and ProD 1–4.
The combined results suggest that both the pKa and the volume of
the leaving group have a significant effect on determining the rate-
limiting step and the magnitude of the barriers. In systems with tri-
fluoromethylamine and di-trifluoromethylamine leaving groups, the
ratio of the tetrahedral intermediate formation to collapse barriers
Table 1: Density functional theory (B3LYP) calculated geometries for GM, INT2, and TS2 in 1–15 and ProD 1–4
System a in GM b in GM a in INT2 b in INT2 a in TS2 b in TS2 h in GM rAP in GM rGM in GM e in GM
1 128.4 132.9 108.7 110.8 121.2 118.4 50.3 3.16 1.56 170.5
2 124.8 127.8 108.1 109.7 119.8 117.7 53.0 3.05 1.53 160.7
3 130.7 128.2 107.4 111.4 123.0 116.7 51.0 3.10 1.50 172.4
4 127.7 132.6 109.1 109.9 118.7 119.7 49.8 3.15 1.53 170.5
5 125.7 129.8 108.1 109.8 118.1 119.2 51.6 3.09 1.52 167.2
6 130.7 128.2 107.2 109.2 123.0 116.6 51.4 3.09 1.51 167.9
7 130.9 128.2 107.2 109.7 123.1 116.5 51.1 3.09 1.50 170.9
8 129.9 130.6 109.0 108.1 121.8 118.5 51.0 3.11 1.51 172.1
9 120.5 122.2 108.7 110.2 118.5 117.4 56.8 3.05 1.72 143.6
10 128.0 133.3 110.2 108.5 120.5 118.8 51.2 3.17 1.60 169.0
11 127.5 133.7 109.0 108.9 120.4 118.9 51.3 3.20 1.64 167.1
12 119.3 122.5 109.8 109.3 113.8 116.2 56.4 3.10 1.82 138.2
13 128.0 133.5 110.7 108.6 121.4 118.5 49.7 3.19 1.57 169.0
14 119.6 121.6 110.3 108.8 118.0 115.7 67.9 2.89 1.80 146.1
15 122.8 125.1 109.9 108.1 119.7 117.5 63.2 2.92 1.67 155.9
ProD 1 123.2 121.5 108.9 108.0 118.2 117.7 103.5 2.69 3.81 44.8
ProD 2 121.1 120.6 109.2 108.7 119.4 117.4 99.3 2.81 3.72 53.1
ProD 3 127.6 122.2 110.4 107.2 119.8 119.0 101.2 2.77 3.87 43.6
ProD 4 127.7 125.5 109.7 108.3 113.4 117.2 104.1 2.83 4.04 39.3
B3LYP refers to values calculated by B3LYP ⁄ 6-31G (d, p) method. GM, INT2, and TS4 refer to global minimum, intermediate, and transition-state structures,
respectively (see Scheme 4). For the definition of the bond angles a, b, h, and e and distances rGM and rAP, see Chart 1. The angle unit is degree and the rGM
and rAP unit is .
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is much higher than in the cases where methylamine and di-methyl-
amine are the leaving group. This might be attributed to the fact
that trifluoromethyl group is an electron-withdrawing group that
makes the amine moiety a good leaving group in the dissociation
process of the tetrahedral intermediate. Hence, the formation ⁄ col-
lapse barriers ratio is shifted toward the formation, whereas in the
cases where the leaving group is NHCH3 or N(CH3)2, the amine moi-
ety has less ability to leave because of the electron-donating effect
of the methyl group. This result is in accordance with the conclu-
sions drawn by Kluger and Chin (47).
DFT calculated reaction rates versus
experimental values
For drawing credibility to the DFT calculations executed in this
study, the water calculated B3LYP ⁄ 6-31G(d,p) free activation ener-
gies for the tetrahedral intermediate collapse (DGzBW) were corre-
lated with the corresponding experimental free activation energies
(Exp DG). Strong correlation was obtained with a correlation coef-
ficient R = 0.95 (Figure 5A).
In order to confirm that the DFT calculations at B3LYP ⁄ 6-31G (d,p)
level of theory are not dependent on the specific theoretical
method used, the kinetic and thermodynamic properties for pro-
cesses 1–3 were calculated at a higher level, B3LYP ⁄ 311 + G
(d,p)a, and with hybrid GGA (MPW1k) functional (39) as well. The
energy data calculated by the three different methods were exam-
ined for correlation. Strong correlation was found between the
examined values with a correlation coefficient of R = 0.99.
The effective molarities (EM) for processes
1–15 and ProD 1–4
The effective molarity (EM) parameter is commonly used as a mea-
sure for intramolecular efficiency. It is defined as a rate ratio of the
intramolecular reaction and its corresponding intermolecular where
both reactions are driven by the same mechanism. The main factors
determining the EM parameter are ring size, solvent, and reaction
type. Cyclization reactions through intramolecular nucleophilic addi-
tion are much more efficient than intramolecular proton transfers.
Values in the order of 109–1013 M have been measured for the EM
in intramolecular processes occurring through nucleophilic addition,
whereas for proton-transfer processes EM values of <10 M were
obtained (51).
Table 2: Density functional theory (B3LYP ⁄ 6-31G (d,p)) calculated
properties for the acid-catalyzed hydrolysis of acid amides 1–15,












1GM )551.6209552 115.71 – 10.16
1INT2 )551.5899873 113.12 – 20.55
1TS3 )551.9510979 100.58 29.18i –
2GM )630.2556684 133.45 – 10.82
2INT2 )630.2424070 125.08 – 16.16
2TS3 )630.6125865 117.89 57.26i –
3GM )590.9452364 126.16 – 9.40
3INT2 )590.9162845 124.52 – 17.32
3TS3 )591.284155 109.50 45.91i –
4GM )668.3716758 131.90 – 12.30
4INT2 )668.3272626 125.09 – 27.89
4TS3 )668.7001822 116.95 73.72i –
5GM )707.6805570 136.69 – 9.18
5INT2 )707.6689275 122.73 – 19.25
5TS3 )707.6321442 122.88 118.05i –
6GM )630.2606708 132.74 – 5.12
6INT2 )630.2326178 132.45 – 17.59
6TS3 )630.60156591 116.93 52.77i –
7GM )669.5780833 138.31 – 6.20
7INT2 )669.5495044 137.75 – 18.55
7TS3 )669.9185072 124.96 68.64i –
8GM )888.6478787 140.60 – 12.86
8INT2 )888.6201859 137.62 – 22.34
8TS3 )888.9742696 120.84 37.75i –
9GM )1225.6575172 145.62 – 28.29
9INT2 )1225.6422023 147.77 – 26.92
9TS3 )1225.9938255 140.05 33.82i –
10GM )849.3302758 134.63 – 14.15
10INT2 )849.3095129 114.95 – 21.56
10TS2 )849.2721283 122.84 92.14i –
11GM )1186.3372601 145.78 – 25.52
11INT2 )1186.3271376 136.12 – 19.78
11TS2 )1186.2730867 135.57 148.15i –
12GM )1523.3652973 163.37 – 35.90
12INT2 )1523.3731299 154.94 – 28.25
12TS2 )1523.3352867 149.02 119.78i –
13GM )590.9248107 112.69 – 13.43
13INT2 )590.8983010 121.16 – 26.54
13TS2 )590.9074094 117.48 171.92i –
14GM )1264.9706324 153.57 – 15.58
14INT2 )1264.9515630 152.18 – 33.55
14TS2 )1264.9379165 151.77 99.37i –
15GM )669.5621811 139.20 – 7.13
15INT2 )669.5503948 131.65 – 24.71
15TS2 )669.5259892 134.31 108.02i –
ProD1 GM )1268.8689365 172.98 – 32.70
ProD1 INT2 )1268.8710712 171.06 – 29.45
ProD1 TS2 )1268.8183062 169.43 134.62i –
ProD2 GM )1864.2702113 193.14 – 48.80
ProD2 INT2 )1864.2731292 190.94 – 42.27
ProD2 TS2 )1864.2190556 186.37 79.43i –
ProD3 GM )1229.5483175 164.26 – 35.70
ProD3 INT2 )1229.5446492 162.24 – 31.16
ProD3 TS2 )1229.5029859 157.29 92.96i –
ProD4 GM )1190.2238966 161.03 – 36.05
ProD4 INT2 )1190.2183473 156.05 – 34.64













InterGM )631.4579281 141.61 – 2.98
InterINT2 )631.4282861 129.50 – 13.64
InterTS3 )631.7933134 130.70 57.27i –
GM, INT, and TS are global minimum, intermediate, and transition-state
structures, respectively. MM2Es is the strain energy calculated by Allinger's
MM2 method.
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Table 4: Density functional theory (DFT) (B3LYP) calculated kinetic and thermodynamic properties for the acid-catalyzed hydrolysis of 1–






















1 32.29 33.06 0 7.724 8.52 20.55 25.08 10.16 25.01 26.10
2 17.56 20.05 4.371 15.86 18.08 16.16 18.93 10.82 16.49 17.90
3 27.93 28.42 1.494 7.742 11.93 17.32 21.70 9.40 22.91 24.80
4 35.76 38.11 )4.377 1.255 4.81 27.89 32.75 12.30 28.67 32.16
5 18.96 23.12 2.732 15.190 15.82 19.25 23.13 9.18 15.57 17.89
6 27.19 27.28 1.516 6.962 12.76 17.59 22.95 5.12 21.86 23.87
7 27.38 27.55 1.648 8.568 12.57 18.55 24.00 6.20 22.86 24.40
8 29.23 30.12 – – 6.36 22.34 27.77 12.86 21.08 23.66
9 15.79 15.15 – – 21.68 26.92 35.64 28.29 10.20 11.97
10 18.76 24.64 – – 11.47 26.92 35.64 28.29 25.53 29.04
11 16.14 19.02 – – 6.06 21.56 25.08 14.15 33.37 36.41
12 6.28 8.79 – – 16.01 19.78 25.08 25.52 18.59 22.87
13 15.94 13.42 – – 18.75 28.25 35.64 35.90 20.66 19.13
14 14.85 15.29 – – 21.28 26.54 25.08 13.43 15.16 15.70
15 12.79 15.04 – – 20.49 33.55 35.64 15.58 15.32 16.78
ProD 1 1.57 2.07 – – 13.36 24.71 – 7.13 25.40 26.46
ProD 2 0 0.66 – – 9.66 29.45 – 32.70 29.48 31.50
ProD 3 1.26 2.26 – – 15.94 42.27 – 48.80 20.88 22.96
ProD 4 0.94 2.92 – – 13.91 31.16 – 35.70 22.19 25.73
Inter 41.30 44.65 – – – 13.64 12.10 – – –
EM, effective molarities; GM, global minimum structures.
B3LYP refers to values calculated by B3LYP ⁄ 6-31G (d, p) method. DH is the calculated activation enthalpic energy (kcal ⁄mol). TDS is the calculated activation
entropic energy (kcal ⁄mol). DG is the calculated activation free energy (kcal ⁄mol). Es refers to strain energy calculated by Allinger's MM2 method (50). INT2
and P refer to intermediate 2 and product, respectively. EM ¼ exp ðDGzinter  DGzintraÞ=RT . BW and FW refer to tetrahedral intermediate breakdown and
tetrahedral intermediate formation calculated in water, respectively. Exp refers to experimental value. Calc refers to DFT calculated values.
Table 3: Density functional theory (B3LYP) calculated kinetic and thermodynamic properties in the gas phase for the acid-catalyzed hydroly-


















1 27.31 )0.77 28.08 32.46 )1.09 33.53 34.27 31.35
2 13.93 )2.49 16.42 25.67 )1.41 27.08 16.32 21.29
3 24.41 )0.49 24.90 30.68 )1.89 32.57 29.53 28.23
4 34.42 )2.35 36.77 41.88 )3.49 45.37 40.23 39.27
5 13.25 )4.16 17.41 24.55 )2.32 26.87 18.51 22.34
6 23.83 )0.09 23.92 30.11 )2.01 32.12 29.53 27.50
7 24.86 )0.17 25.03 30.76 )1.54 32.30 28.35 27.76
8 24.08 )0.89 24.87 29.79 )2.58 32.37 – –
9 17.88 0.64 17.24 24.17 )1.77 25.94 – –
10 13.66 )5.86 19.52 36.49 )3.51 40.00 – –
11 15.06 )2.88 17.94 40.27 )3.04 43.31 – –
12 0 )2.51 2.51 18.83 )4.28 23.11 – –
13 22.91 2.52 20.39 27.62 1.43 26.19 – –
14 19.54 )0.44 19.98 20.53 )0.54 21.07 – –
15 13.04 )2.25 15.29 22.71 )1.46 24.27 – –
ProD 1 4.08 )0.57 4.65 31.77 )1.06 32.83 – –
ProD 2 0 )0.66 0.66 32.10 )2.02 34.12 – –
ProD 3 2.20 )0.60 2.80 28.45 )2.08 30.53 – –
ProD 4 3.45 )1.48 4.93 30.50 )3.54 34.04 – –
Inter 39.90 )3.35 43.25 – – – – –
B3LYP refers to values calculated by B3LYP ⁄ 6-31G (d, p) method. DH is the calculated activation enthalpic energy (kcal ⁄mol). TDS is the calculated activation
entropic energy (kcal ⁄mol). DG is the calculated activation free energy (kcal ⁄mol). B and F refer to tetrahedral intermediate breakdown and tetrahedral inter-
mediate formation. GP and ether refer to calculated in the gas phase and in ether, respectively.
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For obtaining the EM values for processes 1–15 and ProD 1–4,
we have calculated the kinetic and thermodynamic parameters for
their corresponding intermolecular process, Inter (Scheme 5).
Using eqns 1–4, eqn 5 was derived. Equation 5 describes the
EM term as a function of the difference in the activation
energies of the intramolecular process and the corresponding
A B
C D
Figure 3: (A) Plot of DG versus rAP in 1–9, where the blue points for the calculated density functional theory (DFT) values (in water) and
the pink points for the gas-phase calculated values. (B) Plot of DG versus h in 1–9, where the blue points for the water calculated DFT val-
ues and the pink points for the gas-phase calculated values. (C) Plot of Es (INT-GM) versus DG
 in 1–9, where the blue points for the experi-
mental values and the pink points for the water calculated DFT values. (D) Plot of DGzF versus DG
z
B in 1–9, where the blue points for the
water DFT calculated values and the pink points for the gas-phase DFT calculated values. rAP is the distance between the hydroxyl oxygen of
the carboxylic group and the carbon of the amide carbonyl in the reactant. h is the angle of attach of the approach of the carboxylic hydroxyl
group toward the amide carbonyl carbon in the reactant. Es is strain energy, DG
 is the free activation energy. DGzF and DG
z
B refer to the
free activation energy for the tetrahedral intermediate formation and collapse, respectively.
Figure 4: A representation of an energy profile for acid-catalyzed hydrolysis of ProD 1 and 2 as calculated in water. GM. TS, INT, and P
refer to global minimum, transition-state, intermediate, and product structures, respectively. TS2 and TS3 are approach and dissociation transi-
tion-state structures, respectively.
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intermolecular processes. The calculated EM values for processes
1–15 and ProD 1–4 as calculated by eqn 5 are listed in
Table 4.
EM ¼ kintra=kinter ð1Þ
DGzinter ¼ RT lnkinter ð2Þ
DGzintra ¼ RT lnkintra ð3Þ
DGzintra  DGzinter ¼ RT lnkintra=kinter ð4Þ
ln EM ¼ ðDGzintra  DGzinterÞ=RT ð5Þ
where T is the temperature in Kelvin and R is the gas constant.
The calculated log EM values in Table 4 were correlated with the
corresponding EM experimental values. The correlation equation
with its correlation coefficient is shown in Figure 5B and eqn 6.
Careful examination of the calculated log EM values listed in
Table 4 and Figure 5B demonstrated that 2, 5, and 13–15 were
the most efficient processes among 1–15, whereas process 4, 8,
and 11 were the least. The discrepancy in rates between 2, 5,
and 13–15 on the one hand and 4, 8, and 11 on the other hand
is attributed to strain effects.
The calculated and experimental EM values were found to be com-
parable; however, there is a discrepancy in their absolute values.
This might be due to the fact that the EM experimental measure-
ment for the systems studied was taken in the presence of aqueous
acid medium, whereas the DFT calculations were made in plain
water. The dielectric constant value for a mixture of acid ⁄water is
expected to be different from that of water (78.39) and hence the
discrepancy in the calculated and experimental EM valuesb.
log EM (calculated) ¼ 0:809log EM (experimental)
þ 4:75R2 ¼ 0:86 ð6Þ
Calculation of the t1 ⁄ 2 values for the acid-
catalyzed hydrolysis of prodrugs ProD 1–4
The calculated DFT properties for processes ProD 1–4 including
the geometries of GM, intermediate (INT2), and transition-state
(TS2) structures are shown in Figure 2 and listed in Tables 1–4.
Comparison of these calculated structures to that for processes 1–
15 revealed a close similarity.





B and the t1 ⁄ 2 value for process 2,
t1 ⁄ 2 = 1 second (36), we have calculated the t1 ⁄ 2 values for ProD
1–4. The calculated t1 ⁄ 2 values at pH 2 for ProD 1–ProD 4 are
29.2 h, 6097 days, 4.6 min, and 8.34 h, respectively.
logkrel ¼ 0:442DGzB þ 13:534R 2 ¼ 0:93 ð7Þ
DGzF ¼ 0:798DGzB þ 1:346R2 ¼ 0:94 ð8Þ
Conclusions and Future Directions
The DFT calculations at B3LYP ⁄ 6-31G(d,p) level for the acid-cata-
lyzed hydrolysis in acid amides 1–15 and ProD 1–4 demonstrated
that the reaction proceed via four steps where the tetrahedral inter-
mediate formation and its collapse are the two main barriers deter-
mining the rate-limiting step. The calculation results revealed that
when the reaction is carried out in the gas phase or in apolar sol-
vents, the higher barrier is the formation of the tetrahedral interme-
diate, whereas when the reaction medium is water or polar
solvent, the rate-limiting step in processes 1–9 is the tetrahedral
intermediate collapse and in systems 10–15 and ProD 1–4 is
A B
Figure 5: (A) Plot of DG (Calculated) versus DG (Experimental) in 1–9. DG (Calculated) and DG (Experimental) are the water calcu-
lated density functional theory (DFT) free activation energy and experimental free activation energy, respectively. (B) log EM (calc) versus log
EM (exp) in 1–9. EM refers to effective molarity; calc and exp refer to calculated by DFT and experimental, respectively.
Scheme 5: Corresponding intermolecular reaction for 1–15
and ProD1–4.
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the tetrahedral intermediate formation. Furthermore, the calculations
demonstrated that the efficiency of these processes is largely sensi-
tive to the pattern of substitution on the carbon–carbon double
bond and the nature of the amide N-alkyl group. The reaction rate
was found to be linearly correlated with the following characteris-
tics: (i) the strain energy difference between the intermediate and
the reactant (Es INT-GM), (ii) the distance between the hydroxyl oxy-
gen of the carboxyl group and the amide carbonyl carbon (rAP), and
(iii) the attack angle h by which the approach step commences. In
addition, a linear correlation between the calculated and experi-
mental EM values reinforces the credibility of using DFT methods in
predicting energies as well as the rates for reactions of the type
described herein.
Using the correlation equation obtained from the plot of the calcu-
lated and experimental EM values, we have calculated the t1 ⁄ 2 of
four different acyclovir prodrugs (ProD 1–4). The t1 ⁄ 2 values of
those products were dependent on the nature of the substitution
on the C–C double bond.
The strategy to achieve desirable prodrugs of acyclovir that are
capable of releasing acyclovir in a slow release manner is as fol-
lows: (i) synthesis of the linker and coupling of the parent drug to
the linker using Kirby's synthetic procedure were carried out (36);
(ii) kinetic studies (in vitro) of the synthesized prodrugs will be per-
formed in physiological environment (37 C, pH = 2.0 and 6.0 in
aqueous medium); and (iii) for the prodrugs that show desirable
slow release in the in vitro studies, in vivo pharmacokinetic studies
will be conducted in order to determine the bioavailability and the
duration of action of the tested prodrugs. In light of the in vivo
pharmacokinetics, new prodrugs will be designed and synthesized.
It should be emphasized that further studies of factors that are not
accessible to calculations should be made because the bioavailabil-
ity of prodrugs ProD1–ProD4 is not precisely predicted from
their structures owing to the influence of physiological bases and
acids that are likely to influence the overall rates and the stability
of the prodrug in the acid stomach environment.
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